TAIYO KAGAKU CO. LTD.TT

TAIYO KAGAKU CO. LTD.

1,795JPYD
+9+0.50%
At close at 06:02 GMT
JPY
No trades
See on Supercharts

2902 fundamentals

Key facts

Market capitalization‪31.39 B‬JPY
Founded1946
CEO
About

Taiyo Kagaku Co., Ltd. engages in the development, manufacture and sale of emulsifiers, essences, egg and tea-based ingredients, processed fruit products, stabilizers, and medical-related products. It operates through the following segments: Nutrition, Interface Solutions and Natural ingredients. The Nutrition segment includes the development and sale of catechins, theanine, tea-related products, functional food ingredients, vitamins, minerals, and polyunsaturated fatty acids. The Interface Solutions segment sells emulsifiers, stabilizers, thickeners, and chemical products. The Natural ingredients segment deals with ingredients such as eggs and thickening polysaccharides are not only delicious and nutritious, but also have various functions such as solidifying and stabilizing foods. The company was founded in May 1946 and is headquartered in Yokkaichi, Japan.

Ownership
‪‪16.87 M‬‬
Closely held shares
‪‪10.87 M‬‬ (64.42%)
Free Float shares
‪‪6.00 M‬‬ (35.58%)
Closely held shares
‪‪10.87 M‬‬ (64.42%)
Free Float shares
‪‪6.00 M‬‬ (35.58%)
Capital structure
Market cap
‪‪31.39 B‬‬
Debt
‪‪378.85 M‬‬
Minority interest
‪‪1.70 B‬‬
Cash & equivalents
‪‪9.50 B‬‬
Enterprise value
‪‪23.97 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪31.39 B‬‬
Price to earning ratio (P/E)
8.67x
Price to sales ratio (P/S)
0.62x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
8.67x
Price to sales ratio (P/S)
0.62x
Valuation ratios
‪0.00‬
‪0.15‬
‪0.30‬
‪0.45‬
‪0.60‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪3.00‬
‪6.00‬
‪9.00‬
‪12.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−3.5%‬
‪0.0%‬
‪3.5%‬
‪7.0%‬
‪10.5%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−5.00 B‬‬
‪0.00‬
‪‪5.00 B‬‬
‪‪10.00 B‬‬
‪‪15.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪3.50 B‬‬
‪‪7.00 B‬‬
‪‪10.50 B‬‬
‪‪14.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪3.50 B‬‬
‪‪7.00 B‬‬
‪‪10.50 B‬‬
‪‪14.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Natural Ingredient
Interface Solution
Nutrition
Other
By country
Period: 2023
Japan
Asia
America
Europe

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪3.50 B‬‬
‪‪7.00 B‬‬
‪‪10.50 B‬‬
‪‪14.00 B‬‬
Actual
Estimate
Earnings
Next:May 12, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪20.00‬
‪40.00‬
‪60.00‬
‪80.00‬
Actual

Dividends

Dividend yield, history and sustainability

Dividend summary
26.71%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
3.08%
Next payment
65.00
Next ex-date
Mar 28, 2025
Dividend history
‪2.50%‬
‪2.85%‬
‪3.20%‬
‪3.55%‬
‪3.90%‬
2019
2020
2021
2022
2023
‪0.00‬
‪16.00‬
‪32.00‬
‪48.00‬
‪64.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
‪‪36.00 B‬‬
Assets
Liabilities